Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
The American Journal of the Medical Sciences|May 1, 2012
Critical appraisal of the guidelines for the management of ankylosing spondylitis: disease-modifying antirheumatic drugsEnrique R Soriano, Daniel O Clegg, Jeffrey R LisseJournal of the American Geriatrics Society|July 30, 2008
Self-reported osteoarthritis, ethnicity, body mass index, and other associated risk factors in postmenopausal women-results from the Women's Health InitiativeNicole C Wright, Gail Kershner Riggs, Jeffrey R Lisse, et al.The Journal of Rheumatology|May 17, 2011
Arthritis increases the risk for fractures--results from the Women's Health InitiativeNicole C Wright, Jeffrey R Lisse, Brian T Walitt, et al.Bone|January 12, 2010
Relationship of total body fat mass to weight-bearing bone volumetric density, geometry, and strength in young girlsJoshua N Farr, Zhao Chen, Jeffrey R Lisse, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 20, 2010
Lower trabecular volumetric BMD at metaphyseal regions of weight-bearing bones is associated with prior fracture in young girlsJoshua N Farr, Rita Tomás, Zhao Chen, et al.Rheumatology International|May 9, 2019
Management of asymptomatic coccidioidomycosis in patients with rheumatic diseasesJawad Bilal, Shubha Kollampare, Barbara Bode, et al.The Lancet. Rheumatology|February 21, 2025
The effect of ixekizumab treatment on MRI sacroiliac joint structural lesions in patients with radiographic axial spondyloarthritis: post-hoc analysis of a 52-week, randomised, placebo-controlled trial with an active reference armWalter P Maksymowych, Robert G W Lambert, Rebecca J Bolce, et al.The Journal of Rheumatology|April 3, 2013
Efficacy and safety of belimumab in patients with rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled, dose-ranging StudyWilliam Stohl, Joan T Merrill, James D McKay, et al.RMD Open|January 31, 2024
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysisPhilip J Mease, Soumya Reddy, Sarah Ross, et al.Arthritis Care & Research|June 30, 2012
Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugsSara Taroumian, Susan L Knowles, Jeffrey R Lisse, et al.Pageof 3